AbbVie (ABBV) Is Considered a Good Investment by Brokers: Is That True?
The average brokerage recommendation (ABR) for AbbVie (ABBV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

What's Your Reaction?









